1. Karanth, Santhosh, Zinkhan, Erin K, Hill, Jonathon T, Yost, H Joseph, Schlegel, Amnon. 2016. FOXN3 Regulates Hepatic Glucose Utilization. In Cell reports, 15, 2745-55. doi:10.1016/j.celrep.2016.05.056. https://pubmed.ncbi.nlm.nih.gov/27292639/
2. Yu, Wei, Diao, Yongkang, Zhang, Yi, Huang, Dongsheng, Zhang, Jungang. 2022. Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer. In Frontiers in oncology, 12, 1008100. doi:10.3389/fonc.2022.1008100. https://pubmed.ncbi.nlm.nih.gov/36324573/
3. Karanth, Santhosh, Chaurasia, Bhagirath, Bowman, Faith M, Summers, Scott A, Schlegel, Amnon. . FOXN3 controls liver glucose metabolism by regulating gluconeogenic substrate selection. In Physiological reports, 7, e14238. doi:10.14814/phy2.14238. https://pubmed.ncbi.nlm.nih.gov/31552709/
4. Yang, Hua, Li, Mingyu, Qi, Yue. 2023. FOXN3 inhibits the progression of ovarian cancer through negatively regulating the expression of RPS15A. In Human cell, 36, 1120-1134. doi:10.1007/s13577-023-00876-9. https://pubmed.ncbi.nlm.nih.gov/37016167/
5. Karanth, Santhosh, Adams, J D, Serrano, Maria de Los Angeles, Vella, Adrian, Schlegel, Amnon. . A Hepatocyte FOXN3-α Cell Glucagon Axis Regulates Fasting Glucose. In Cell reports, 24, 312-319. doi:10.1016/j.celrep.2018.06.039. https://pubmed.ncbi.nlm.nih.gov/29996093/
6. Wang, Yaqi, Su, Hui, Wang, Xiaopeng, Ren, Bincheng, Wang, Shuang. 2024. FOXN3 Regulates Autophagic Activity to Suppress Drug Resistance in Melanoma Cells. In Clinical, cosmetic and investigational dermatology, 17, 2505-2518. doi:10.2147/CCID.S462854. https://pubmed.ncbi.nlm.nih.gov/39530064/
智鼠故事 
